Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease

Overview of attention for article published in BMC Medicine, June 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

blogs: 1 blog

twitter: 31 X users

Citations

dimensions_citation: 38 Dimensions

Readers on

mendeley: 57 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 38 X posts from 31 X users, with an upper bound of 142,406 followers.

When we first reported on this cohort in 2020, it was a simple, happy story: https://t.co/1CirVtdWYe CSF PrP had good test-retest stability, meaning it could be a pharmacodynamic biomarker.

20 Dec 2023

Reply Repost Favourite

Then Sonia talks about RT-QuIC or plasma biomarker for #EarlyDiagnosis and #TrialEndPoints #solveRD... 👇 "markers of prion seeding activity & neuronal damage do not reliably cross-sectionally distinguish mutation carriers from controls" https://t.co/

25 Apr 2022

Reply Repost Favourite

.@cureffi: What is the natural history of PrP in mutation carriers vs controls? Overall, most healthy mutation carriers seemed normal on metrics checked compared to controls. https://t.co/mCcZWqkOY8 #GRD21

23 Mar 2021

Reply Repost Favourite

Work is being done.. The March forward never ceases.

07 Jul 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 34 additional X posts.